Vector saliva in vaccines for visceral leishmaniasis: A brief encounter of high consequence?

Frontiers in Public Health

Volumn 2, Issue AUG, 2014, Pages

  Kamhawi, Shaden ^a   Aslan, Hamide ^a   Valenzuela, Jesus G ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Delayed type hypersensitivity response; Salivary proteins as vaccines; Sand fly vectors; Th1 immune response; Vector transmission; Visceral leishmaniasis

Indexed keywords

EID: 84919464129     PISSN: None     EISSN: 22962565     Source Type: Journal    
DOI: 10.3389/fpubh.2014.00099     Document Type: Article

References (67)

1. Chappuis F, Sundar S, Hailu A, Ghalib H, Rijal S, Peeling RW, et al. Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? Nat Rev Microbiol (2007) 5(11):873-82. doi:10.1038/nrmicro1748
2. Alvar J, Velez ID, Bern C, Herrero M, Desjeux P, Cano J, et al. Leishmaniasis worldwide and global estimates of its incidence. PLoS One (2012) 7(5):e35671. doi:10.1371/journal.pone.0035671
3. Lukes J, Mauricio IL, SchonianG, Dujardin JC, SoteriadouK, Dedet JP, et al. Evo- lutionary and geographical history of the Leishmania donovani complex with a revision of current taxonomy. Proc Natl Acad Sci U S A (2007) 104(22):9375-80. doi:10.1073/pnas.0703678104
4. Alvar J, Canavate C, Molina R, Moreno J, Nieto J. Canine leishmaniasis. Adv Parasitol (2004) 57:1-88. doi:10.1016/S0065-308X(04)57001-X
5. Nasereddin A, Baneth G, Schonian G, Kanaan M, Jaffe CL. Molecular fin- gerprinting of Leishmania infantum strains following an outbreak of vis- ceral leishmaniasis in central Israel. J Clin Microbiol (2005) 43(12):6054-9. doi:10.1128/JCM.43.12.6054-6059.2005
6. Bader KA, Schnur LF, Nasereddin A, Pratlong F, Dedet JP, Shaheen L, et al. Palestinian infantile visceral leishmaniasis caused by a genetic variant of Leish- mania infantum belonging to a new zymodeme. Trop Med Int Health (2005) 10(6):618-20. doi:10.1111/j.1365-3156.2005.01419.x
7. Desjeux P. Leishmaniasis. Public health aspects and control. Clin Dermatol (1996) 14(5):417-23. doi:10.1016/0738-081X(96)00057-0
8. Tiwary P, Kumar D, Singh RP, Rai M, Sundar S. Prevalence of sand flies and Leishmania donovani infection in a natural population of female Phlebotomus argentipes in Bihar State, India. Vector Borne Zoonotic Dis (2012) 12(6):467-72. doi:10.1089/vbz.2011.0808
9. Tiwary P, Kumar D, MishraM, Singh RP, RaiM, Sundar S. Seasonal variation in the prevalence of sand flies infected with Leishmania donovani. PLoSOne (2013) 8(4):e61370. doi:10.1371/journal.pone.0061370
10. ElnaiemDE. Ecology and control of the sand fly vectors of Leishmania donovani in East Africa, with special emphasis on Phlebotomus orientalis. J Vector Ecol (2011) 36(Suppl 1):S23-31. doi:10.1111/j.1948-7134.2011.00109.x
11. Dereure J, Rageh HA, Daoud W, Rioux JA. Eco-epidemiology of visceral and cutaneous leishmaniasis in the Arab Republic of Yemen. II. A survey using intradermal reaction to leishmanin in a zone of mixed infestation with Leish- mania tropica, L. donovani and L. infantum. Bull Soc Pathol Exot Filiales (1989) 82(5):665-8.
12. Ready PD. Leishmaniasis emergence in Europe. Euro Surveill (2010) 15(10):19505.
13. Giorgobiani E, Lawyer PG, Babuadze G, Dolidze N, Jochim RC, Tskhvaradze L, et al. Incrimination of Phlebotomus kandelakii and Phlebotomus balcanicus as vectors of Leishmania infantum in Tbilisi, Georgia. PLoS Negl Trop Dis (2012) 6(4):e1609. doi:10.1371/journal.pntd.0001609
14. Silva ES, Gontijo CM, Pacheco RS, Fiuza VO, Brazil RP. Visceral leishmani- asis in the Metropolitan Region of Belo Horizonte, State of Minas Gerais, Brazil. Mem Inst Oswaldo Cruz (2001) 96(3):285-91. doi:10.1590/S0074-02762001000300002
15. Lainson R, Rangel EF. Lutzomyia longipalpis and the eco-epidemiology of Amer- ican visceral leishmaniasis, with particular reference to Brazil: a review. MemInst Oswaldo Cruz (2005) 100(8):811-27. doi:10.1590/S0074-02762005000800001
16. Dorlo TP, Balasegaram M, Beijnen JH, de Vries PJ. Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis. J Antimicrob Chemother (2012) 67(11):2576-97. doi:10.1093/jac/dks275
17. Sundar S, Chakravarty J. Liposomal amphotericin B and leishmaniasis: dose and response. J Glob Infect Dis (2010) 2(2):159-66. doi:10.4103/0974-777X.62886
18. Chakravarty J, Sundar S. Drug resistance in leishmaniasis. J Glob Infect Dis (2010) 2(2):167-76. doi:10.4103/0974-777X.62887
19. Meheus F, Balasegaram M, Olliaro P, Sundar S, Rijal S, Faiz MA, et al. Cost- effectiveness analysis of combination therapies for visceral leishmaniasis in the Indian subcontinent. PLoS Negl Trop Dis (2010) 4(9):e818. doi:10.1371/journal.pntd.0000818
20. Bern C, Haque R, Chowdhury R, Ali M, Kurkjian KM, Vaz L, et al. The epi- demiology of visceral leishmaniasis and asymptomatic leishmanial infection in a highly endemic Bangladeshi village. Am J TropMed Hyg (2007) 76(5):909-14.
21. Ribeiro JM, Francischetti IM. Role of arthropod saliva in blood feeding: sialome and post-sialome perspectives. Annu Rev Entomol (2003) 48:73-88. doi:10.1146/annurev.ento.48.060402.102812
22. Kamhawi S. The biological and immunomodulatory properties of sand fly saliva and its role in the establishment of Leishmania infections. Microbes Infect (2000) 2(14):1765-73. doi:10.1016/S1286-4579(00)01331-9
23. Andrade BB, de Oliveira CI, Brodskyn CI, Barral A, Barral-Netto M. Role of sand fly saliva in human and experimental leishmaniasis: current insights. Scand J Immunol (2007) 66(2-3):122-7. doi:10.1111/j.1365-3083.2007.01964.x
24. Oliveira F, de Carvalho AM, de Oliveira CI. Sand-fly saliva-man: the trigger trio. Front Immunol (2013) 4:375. doi:10.3389/mmu.2013.00375
25. Belkaid Y, Kamhawi S, Modi G, Valenzuela J, Noben-Trauth N, Rowton E, et al. Development of a naturalmodel of cutaneous leishmaniasis: powerful effects of vector saliva and saliva preexposure on the long-term outcome of Leishmania major infection in the mouse ear dermis. J Exp Med (1998) 188(10):1941-53. doi:10.1084/jem.188.10.1941
26. CarregaroV, CostaDL, BrodskynC, BarralAM, Barral-NettoM, Cunha FQ, et al. Dual effect of Lutzomyia longipalpis saliva on Leishmania braziliensis infection is mediated by distinct saliva-induced cellular recruitment into BALB/c mice ear. BMC Microbiol (2013) 13:102. doi:10.1186/1471-2180-13-102
27. Collin N, Gomes R, Teixeira C, Cheng L, Laughinghouse A, Ward JM, et al. Sand fly salivary proteins induce strong cellular immunity in a natural reservoir of visceral leishmaniasis with adverse consequences for Leishmania. PLoS Pathog (2009) 5(5):e1000441. doi:10.1371/journal.ppat.1000441
28. Gomes R, Oliveira F, Teixeira C, Meneses C, Gilmore DC, Elnaiem DE, et al. Immunity to sand fly salivary protein LJM11 modulates host response to vector-transmitted Leishmania conferring ulcer-free protection. J Invest Der- matol (2012) 132(12):2735-43. doi:10.1038/jid.2012.205
29. Gomes R, Teixeira C, Teixeira MJ, Oliveira F, Menezes MJ, Silva C, et al. Immu- nity to a salivary protein of a sand fly vector protects against the fatal outcome of visceral leishmaniasis in a hamster model. Proc Natl Acad Sci U S A (2008) 105(22):7845-50. doi:10.1073/pnas.0712153105
30. Kamhawi S, Belkaid Y, Modi G, Rowton E, Sacks D. Protection against cuta- neous leishmaniasis resulting from bites of uninfected sand flies. Science (2000) 290(5495):1351-4. doi:10.1126/science.290.5495.1351
31. Oliveira F, Lawyer PG, Kamhawi S, Valenzuela JG. Immunity to distinct sand fly salivary proteins primes the anti-Leishmania immune response towards protection or exacerbation of disease. PLoS Negl Trop Dis (2008) 2(4):e226. doi:10.1371/journal.pntd.0000226
32. Tavares NM, Silva RA, Costa DJ, Pitombo MA, Fukutani KF, Miranda JC, et al. Lutzomyia longipalpis saliva or salivary protein LJM19 protects against Leish- mania braziliensis and the saliva of its vector, Lutzomyia intermedia. PLoS Negl Trop Dis (2011) 5(5):e1169. doi:10.1371/journal.pntd.0001169
33. Valenzuela JG, Belkaid Y, Garfield MK, Mendez S, Kamhawi S, Rowton ED, et al. Toward a defined anti-Leishmania vaccine targeting vector antigens: char- acterization of a protective salivary protein. J Exp Med (2001) 194(3):331-42. doi:10.1084/jem.194.3.331
34. Morris RV, Shoemaker CB, David JR, Lanzaro GC, Titus RG. Sandfly maxadi- lan exacerbates infection with Leishmania major and vaccinating against it pro- tects against L. major infection. J Immunol (2001) 167(9):5226-30. doi:10.4049/jimmunol.167.9.5226
35. Teixeira C, Gomes R, Oliveira F, Meneses C, Gilmore DC, Elnaiem DE, et al. Characterization of the early inflammatory infiltrate at the feeding site of infected sand flies in mice protected from vector-transmitted Leishmania major by exposure to uninfected bites. PLoS Negl Trop Dis (2014) 8(4):e2781. doi:10.1371/journal.pntd.0002781
36. Peters NC, Egen JG, Secundino N, Debrabant A, Kimblin N, Kamhawi S, et al. In vivo imaging reveals an essential role for neutrophils in leishmaniasis transmitted by sand flies. Science (2008) 321(5891):970-4. doi:10.1126/science.1159194
37. Peters NC, Kimblin N, Secundino N, Kamhawi S, Lawyer P, Sacks DL. Vector transmission of Leishmania abrogates vaccine-induced protective immunity. PLoS Pathog (2009) 5(6):e1000484. doi:10.1371/journal.ppat.1000484
38. Zahedifard F, Gholami E, Taheri T, Taslimi Y, Doustdari F, Seyed N, et al. Enhanced protective efficacy of nonpathogenic recombinant Leishmania taren-tolae expressing cysteine proteinases combined with a sand fly salivary antigen. PLoS Negl Trop Dis (2014) 8(3):e2751. doi:10.1371/journal.pntd.0002751
39. Gomes RB, Brodskyn C, de Oliveira CI, Costa J, Miranda JC, Caldas A, et al. Seroconversion against Lutzomyia longipalpis saliva concurrent with the devel- opment of anti-Leishmania chagasi delayed-type hypersensitivity. J Infect Dis (2002) 186(10):1530-4. doi:10.1086/344733
40. Vinhas V, Andrade BB, Paes F, Bomura A, Clarencio J, Miranda JC, et al. Human anti-saliva immune response following experimental exposure to the visceral leishmaniasis vector, Lutzomyia longipalpis. Eur J Immunol (2007) 37(11):3111-21. doi:10.1002/eji.200737431
41. Oliveira F, Traore B, Gomes R, Faye O, Gilmore DC, Keita S, et al. Delayed- type hypersensitivity to sand fly saliva in humans froma leishmaniasis-endemic area of Mali is Th1-mediated and persists to midlife. J Invest Dermatol (2013) 133(2):452-9. doi:10.1038/jid.2012.315
42. Rosypal AC, Troy GC, Zajac AM, Frank G, Lindsay DS. Transplacental transmis- sion of a North American isolate of Leishmania infantum in an experimentally infected beagle. J Parasitol (2005) 91(4):970-2. doi:10.1645/GE-483R.1
43. Kimblin N, Peters N, Debrabant A, Secundino N, Egen J, Lawyer P, et al. Quantification of the infectious dose of Leishmania major transmitted to the skin by single sand flies. Proc Natl Acad Sci U S A (2008) 105(29):10125-30. doi:10.1073/pnas.0802331105
44. Secundino NF, de Freitas VC, Monteiro CC, Pires AC, David BA, Pimenta PF. The transmission of Leishmania infantum chagasi by the bite of the Lut- zomyia longipalpis to two different vertebrates. Parasit Vectors (2012) 5:20. doi:10.1186/1756-3305-5-20
45. Maia C, Seblova V, Sadlova J, Votypka J, Volf P. Experimental transmission of Leishmania infantum by two major vectors: a comparison between a vis- cerotropic and a dermotropic strain. PLoS Negl Trop Dis (2011) 5(6):e1181. doi:10.1371/journal.pntd.0001181
46. Oliveira F, Kamhawi S, Seitz AE, Pham VM, Guigal PM, Fischer L, et al. From transcriptome to immunome: identification of DTH inducing proteins from a Phlebotomus ariasi salivary gland cDNA library. Vaccine (2006) 24(3):374-90. doi:10.1016/j.vaccine.2005.07.085
47. Xu X, Oliveira F, Chang BW, Collin N, Gomes R, Teixeira C, et al. Structure and function of a "yellow" protein from saliva of the sand fly Lutzomyia longipalpis that confers protective immunity against Leishmania major infection. J Biol Chem (2011) 286(37):32383-93. doi:10.1074/jbc. M111.268904
48. Ready PD. Epidemiology of visceral leishmaniasis. Clin Epidemiol (2014) 6:147-54. doi:10.2147/CLEP.S44267
49. WHO. Control of the leishmaniases. Report of aWHOexpert committee. World Health Organ Tech Rep Ser (2010) 949:1-200.
50. Vlkova M, Sima M, Rohousova I, Kostalova T, Sumova P, Volfova V, et al. Comparative analysis of salivary gland transcriptomes of Phleboto- mus orientalis sand flies from endemic and non-endemic foci of visceral leishmaniasis. PLoS Negl Trop Dis (2014) 8(2):e2709. doi:10.1371/journal.pntd.0002709
51. Valenzuela JG, Garfield M, Rowton ED, Pham VM. Identification of the most abundant secreted proteins from the salivary glands of the sand fly Lutzomyia longipalpis, vector of Leishmania chagasi. J Exp Biol (2004) 207(Pt 21):3717-29. doi:10.1242/jeb.01185
52. Anderson JM, Oliveira F, Kamhawi S, Mans BJ, Reynoso D, Seitz AE, et al. Com- parative salivary gland transcriptomics of sandfly vectors of visceral leishmani- asis. BMC Genomics (2006) 7:52. doi:10.1186/1471-2164-7-52
53. Rohousova I, Subrahmanyam S, Volfova V, Mu J, Volf P, Valenzuela JG, et al. Salivary gland transcriptomes and proteomes of Phlebotomus tobbi and Phle- botomus sergenti, vectors of leishmaniasis. PLoSNegl TropDis (2012) 6(5):e1660. doi:10.1371/journal.pntd.0001660
54. Teixeira C, Gomes R, Collin N, Reynoso D, Jochim R, Oliveira F, et al. Discov- ery of markers of exposure specific to bites of Lutzomyia longipalpis, the vector of Leishmania infantum chagasi in Latin America. PLoS Negl Trop Dis (2010) 4(3):e638. doi:10.1371/journal.pntd.0000638
55. Aslan H, Dey R, Meneses C, Castrovinci P, Jeronimo SM, Oliva G, et al. A new model of progressive visceral leishmaniasis in hamsters by natural trans- mission via bites of vector sand flies. J Infect Dis (2013) 207(8):1328-38. doi:10.1093/infdis/jis932
56. Das S, Freier A, Boussoffara T, Das S, Oswald D, Losch FO, et al. Modularmulti- antigen T cell epitope-enriched DNA vaccine against human leishmaniasis. Sci Transl Med (2014) 6(234):234ra56. doi:10.1126/scitranslmed.3008222
57. Singh B, Sundar S. Leishmaniasis: vaccine candidates and perspectives. Vaccine (2012) 30(26):3834-42. doi:10.1016/j.vaccine.2012.03.068
58. Kamhawi S, Oliveira F, Valenzuela JG. Using humans tomake a human leishma- niasis vaccine. Sci TranslMed (2014) 6(234):234fs18. doi:10.1126/scitranslmed.3009118
59. CourtenayO, Carson C, Calvo-Bado L, Garcez LM, Quinnell RJ. Heterogeneities in Leishmania infantum infection: using skin parasite burdens to identify highly infectious dogs. PLoS Negl Trop Dis (2014) 8(1):e2583. doi:10.1371/journal.pntd.0002583
60. Reis AB, Giunchetti RC, Carrillo E, Martins-Filho OA, Moreno J. Immunity to Leishmania and the rational search for vaccines against canine leishmaniasis. Trends Parasitol (2010) 26(7):341-9. doi:10.1016/j.pt.2010.04.005
61. Ponce C, Ponce E, Morrison A, Cruz A, Kreutzer R, McMahon-Pratt D, et al. Leishmania donovani chagasi: new clinical variant of cutaneous leishmani- asis in Honduras. Lancet (1991) 337(8733):67-70. doi:10.1016/0140-6736(91) 90734-7
62. Pratlong F, Bastien P, Perello R, Lami P, Dedet JP. Human cutaneous leishma- niasis caused by Leishmania donovani sensu stricto in Yemen. Trans R Soc Trop Med Hyg (1995) 89(4):398-9. doi:10.1016/0035-9203(95)90025-X
63. Marty P, Pratlong F, Marcelet B, Adda A, Le Fichoux Y. Leishmania infantum variant MON-24 isolated from a cutaneous lesion acquired in the suburban area of Nice (France). Parasite (1994) 1(2):175-6.
64. Svobodova M, Alten B, Zidkova L, Dvorak V, Hlavackova J, Myskova J, et al. Cutaneous leishmaniasis caused by Leishmania infantum transmitted by Phlebotomus tobbi. Int J Parasitol (2009) 39(2):251-6. doi:10.1016/j.ijpara.2008. 06.016
65. Siriwardana HV, Noyes HA, Beeching NJ, Chance ML, Karunaweera ND, Bates PA. Leishmania donovani and cutaneous leishmaniasis, Sri Lanka. Emerg Infect Dis (2007) 13(3):476-8. doi:10.3201/eid1303.060242
66. Karunaweera ND. Leishmania donovani causing cutaneous leishmaniasis in Sri Lanka: a wolf in sheep's clothing? Trends Parasitol (2009) 25(10):458-63. doi:10.1016/j.pt.2009.07.002
67. Gradoni L, GramicciaM. Leishmania infantum tropism: strain genotype or host immune status? ParasitolToday (1994) 10(7):264-7. doi:10.1016/0169-4758(94) 90142-2